Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 20, 1999

View Archived Issues

Antisense modulation of LFA-3 jointly investigated by Isis and Yale

Millennium announces merger agreements with LeukoSite, Millennium BioTherapeutics and Lilly

Onyx and Warner-Lambert collaborate on development of anticancer virus products

Chiron Behring, Abbott seek to terminate marketing agreements with North American Vaccines

Genzyme jumps on the M&A bandwagon with Cell Genesys acquisition

Mechanism of herbicide analogue XK-469's antitumor activity pinpointed

Multikine may reduce opportunistic infections in patients with HIV

Anti-HSV activity of RC-183 involves a novel mechanism

Novel double-prodrug quinones as effective treatment of solid tumors

Structurally novel PARP inhibitors for cancer, neurodegenerative disorders designed at Pierre Fabre

Major pharmaceutical merger in Japan

Ontogen investigates FBPase as novel target for the treatment of hyperglycemia

Essex Pharma launches clot buster in Germany

U.S. and Israeli researchers disclose angiogenic and antiangiogenic endostatin-derived peptides

Antisense gene therapy technology available for licensing from NIH

Potent new methylprednisolone and betamethasone derivatives show promise for asthma

Glaxo Wellcome makes strides in genetic research

Boston Biomedica forms new subsidiary to develop drugs and vaccines

New drug discovery collaboration with Organon announced by Pharmacopeia

North American Vaccine awarded contract to supply NeisVac-C in U.K.

AnorMed initiates phase III clinical trials in U.S. for Lambda

Human trials initiated for IL-13 cytotoxin under development by NeoPharm

Immune Network Research exercises Alzheimer's technology option

Important product approval obtained by Orion: entacapone cleared for U.S. marketing

Technology acquisition broadens and accelerates ICAgen's R&D programs

Advantageous pharmacokinetic profile reported for HI-240 in mice

Advances in development of vagus nerve stimulation reported by Cyberonics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...